Augmented Reality Training for Cerebral Palsy
TERAPACE
Study of the Usability of an Augmented Reality Exercise for the Cognitive-motor Rehabilitation of Cerebral Palsy (CP) or Acquired Brain Injury (ABI)
1 other identifier
interventional
30
1 country
1
Brief Summary
Rehabilitation programmes for children and adolescents with CP or ABI are not easily accessible, which hinders the development of their physical and cognitive abilities. The Covid-19 pandemic has highlighted the need for specific care for these children and their families. As part of the rehabilitation of these children, it is necessary to offer cognitive-motor or spatial navigation rehabilitation programmes incorporating different sensory stimuli (visual, auditory). In this context, new technologies appear to be a relevant solution for offering fun, personalised rehabilitation with the possibility of remote self-education. Virtual reality is commonly used for paediatric rehabilitation, unlike augmented reality, which is a very recent and promising technology. Before studying the effectiveness of a new augmented reality-based programme, it is essential to assess the usability, user experience, acceptance and potential benefits of this type of device in the cognitive-motor rehabilitation of this population. The investigators have developed an exergame, using an augmented reality (AR) headset, which will eventually offer a new form of rehabilitation, both fun and interactive, for children and teenagers with CP or ABIs. Principal Objective: Assessing the usability of an AR exercise game for children with CP or ABI. Secondary Objectives: Evaluating the user experience (attractiveness, emotions) of an AR exergame for children with CP or ABI Evaluating the acceptance of an AR exergame before and after its use in children with CP or ABI To assess the intrinsic motivation associated with AR exercise for CP and ABI children. To assess the fatigue (mental and physical) associated with exercise in RA in children with CP or ABI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2023
CompletedFirst Submitted
Initial submission to the registry
October 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2025
CompletedApril 25, 2025
April 1, 2025
7 days
October 23, 2024
April 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
System Usability Scale
The children will score 10 statements using a 5-point Likert scale with anchor points at either end ("Strongly disagree" or "Strongly agree"). The scale employs a numerical rating system, with scores ranging from 0 to 100. A score of 85 or above is typically regarded as 'excellent', 75 or above as 'good', and 50 to 75 as 'fair' or 'correct'. A score below 50 indicates a low level of user satisfaction
Immediately after the intervention
Secondary Outcomes (5)
Semantic user experience
Immediately after the intervention
Emotionnal user experience
Immediately after the intervention
Acceptance
Before and Immediately after the intervention
Motivation
Immediately after the intervention
Fatigue
Pre-intervention
Study Arms (1)
exergames
OTHERThere are two exergames: corsi and zoo games
Interventions
Participants play two exergames, the aim of this process is to engage cognitive double tasks
Eligibility Criteria
You may qualify if:
- Children with CP or ABI, aged between 10 and 16.
- Children with sufficient listening comprehension skills
- Membership of the French social security system
- Children who have given their consent
- Obligation to obtain written informed consent from legal representatives
You may not qualify if:
- Children with a Gross Motor Function Classification System (GMFCS) motor score of over 3
- Children with contraindications to the use of new technologies (e.g. photosensitive epilepsy)
- Children with atypical or uncorrected visual and/or hearing impairment
- Children with unstable medical conditions
- Simultaneous participation in another research protocol that could have an influence on the evaluation of the PLAR system
- Refusal by the child or the family
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Julia HAMONET-TORNY
Limoges, 87025, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julia HAMONEt-TORNY, MD
Centre Hospitalier Esquirol
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 23, 2024
First Posted
April 25, 2025
Study Start
November 22, 2023
Primary Completion
November 29, 2023
Study Completion
November 6, 2024
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share